Biosimilar Newsletter Archive
-
01.09.25 -- AP Biosciences' Approach To Complex Antibody Manufacturing
1/9/2025
01/09/25 Biosimilar Development Newsletter
-
01.02.25 -- Cell Culture Trends To Watch In 2025
1/2/2025
01/02/25 Biosimilar Development Newsletter
-
12.19.24 -- How To Ensure 21 CFR Part 11 Compliance
12/19/2024
12/19/24 Biosimilar Development Newsletter
-
12.19.24 -- 4 Technologies To Transform The Supply Chain in 2025
12/19/2024
12/19/24 Biosimilar Development Newsletter
-
12.15.24 -- Is The BIOSECURE Act The First Real Step Toward Reshoring?
12/15/2024
12/15/24 Biosimilar Development Newsletter
-
12.13.24 -- All Eyes On Sustainability
12/13/2024
12/13/24 Biosimilar Development Newsletter
-
12.12.24 -- Is The BIOSECURE Act The First Real Step Toward Reshoring?
12/12/2024
12/12/24 Biosimilar Development Newsletter
-
12.05.24 -- Filter Integrity Testing Annex 1 Requirements For Biologics DS
12/5/2024
12/05/24 Biosimilar Development Newsletter
-
11.27.24 -- A Comprehensive Guide For Supplier Quality Agreements
11/27/2024
11/27/24 Biosimilar Development Newsletter
-
11.21.24 -- Tips For Addressing Vaccine Demand – Strategies For C&G And mRNA
11/21/2024
11/21/24 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more